A good marketing plan for pharmaceutical investment allows you to enjoy success

Frankly speaking, the successful rate of investment in many products is not high. Even so, there are still many companies rushing and bustling. The reason is nothing more than trying to set aside funds for funds, and leveraging the power of other people’s networks or channel resources to quickly Its own products spread all over the country, its name is beautiful, the industry has a division of labor, the demand is different. However, the desire is good, and confidence is sufficient, but don’t forget why others want to favor you in the cloud of opponents and numerous choices. What do you mean by attracting others' core competencies?

A pharmaceutical investment enterprise, if it has good products, is far from enough. The key is to have good promotion methods. In fact, not only is the market, many legends of celebrity experience also explain this truth. For example, Pavarotti. A few years ago, the splendid and penetrating voice of Pavarotti became loud and the singer Pavarotti disappeared. In the second half of the 20th century, Pavarotti attracted the attention of opera spectators with his extraordinary singing skills and was hailed as the greatest tenor of his generation.

For decades, even though Pavarotti had a God-given Golden Scorpion, the singer known as "The King of High C" and "The World's Chief Tenor" didn't actually get a score, if not carefully planned, designed and promoted. It is also unlikely that a global cultural industry chain will be derived. His agent, excellent marketing expert Herbert. Brylin contributed. For example, in 1991, in Hyde Park in England, an unprecedented concert was held for Pavarotti, and 120,000 viewers watched with heavy rain. "Three tenor concerts" is another successful case of Pavarotti brand development. The most recent commercial essay was Pavarotti's farewell global tour that was launched in 2005.

From this point of view, even if one is talented, one needs careful planning and Packaging. Otherwise, you just have a good product, there is no good promotion method, that is, a pile of inventory. There are often many business owners consulting, before the formal interview, they are very impressed with the love of the products. The products in the hands are either exclusive patents or rare technologies. Some of them also come up with a large amount of written materials highly appraised by relevant media and senior experts of an authoritative organization. According to them, they think that such a good product must have great prospects. There will certainly be a good market. The agents and distributors of pharmaceutical investment will be interested and will continue to negotiate cooperation. Therefore, the market will appear as if "it is like a night of spring breeze, thousands of trees pear blossom" landscape, is it true?

naive! If pharmaceutical investment enterprises only have the advantages of R&D and production, even the best products will not be successful. Whether you are abroad or where, because in a highly homogenized product your so-called advantage does not come from the market, plainly, that you think is an advantage, consumers do not think so, in the health care products and fast In consumer products, the perceived core competitive advantage should be marketing planning.

Thanks to good pharmaceutical investment planning and good marketing methods, we can turn your product's shortcomings into features, and features become selling points. Selling points eventually become the excitement of the market, and all the way to attack the city and seize the share. The reason why the vast majority of unsuccessful companies fail is to follow the concept of "good products - good teams - good planning". It is also easy to see that they are obsessed with developing and producing material things. Satisfaction, while superstitiously cultivating its own team for many years, precisely does not attach importance to the marketing plan for the success or failure of the entire pharmaceutical investment enterprise, and does not dare to spend money to find the brain, is not willing to pay for wisdom, and even lacks or lacks awareness of this aspect. As a result, the product died and the court fell. The initial ambition brought us an empty bag. It is sad and sad.

In fact, companies that have succeeded in attracting investment attach great importance to putting planning first. They endow products with soul and give them ethos and cultural quality. Pharmaceutical investment companies that are unsuccessful in attracting investment often put their products first, and they think that they are strong in foreign countries. Behind the fact is only the form. No agent is interested in this point. Imagine having a good planning and profit model, plus the unique effect of the product itself. How effective is the product? Can not cause attention to attract eye-catching planning, and finally, you uselessly complain.